Structured Summary:
In patients with type 2 diabetes mellitus (T2DM) and elevated atherosclerotic cardiovascular disease (ASCVD) risk, Curcumin supplementation significantly improved blood pressure, blood glucose control, lipid profiles, and overall cardiovascular health compared to standard care alone,
though it was associated with mild gastrointestinal effects.
| PICO | Description |
|---|---|
| Population | Adult patients with type 2 diabetes mellitus (T2DM) and atherosclerotic cardiovascular disease (ASCVD) risk score of ≥ 5%. |
| Intervention | Curcumin supplementation (specific dosage not stated). |
| Comparison | Standard care without Curcumin supplementation. |
| Outcome | Curcumin led to significant reductions in blood pressure, improved blood glucose levels (likely HbA1c), and better lipid profiles. It enhanced overall cardiovascular health but was associated with mild gastrointestinal side effects. |
Source: Omar M El-Rakabawy, et al. “Curcumin supplementation improves the clinical outcomes of patients with diabetes and atherosclerotic cardiovascular risk.” Read article here.
